Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks, LLC, is a clinical stage biotechnology company that offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic and colorectal cancers. The company’s services include development of pharmaceutical and diagnostic products for the early detection and treatment of cancer and developing innovative diagnostics and therapeutics that target tumors with precision. PBI also provides therapeutic drug candidate for pancreatic and colorectal cancers, therapeutic drug, tumor specific antigen, pre clinical tests, experimental therapy, and other diagnostic programs. Its services include discovery, development and commercialization of novel cancer therapeutics and diagnostics. The company has operations in Dallas, Rockville, and New York. PBI is headquartered in Dallas, Texas, the US. Precision Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and... Research Beam Model: Research Beam Product ID: 2114458 250 USD New
Precision Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Precision Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : September   2017
  • Pages : 27
  • Publisher : GlobalData
 
 
 
Summary

Precision Biologics Inc (PBI), a subsidiary of NantWorks, LLC, is a clinical stage biotechnology company that offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic and colorectal cancers. The company’s services include development of pharmaceutical and diagnostic products for the early detection and treatment of cancer and developing innovative diagnostics and therapeutics that target tumors with precision. PBI also provides therapeutic drug candidate for pancreatic and colorectal cancers, therapeutic drug, tumor specific antigen, pre clinical tests, experimental therapy, and other diagnostic programs. Its services include discovery, development and commercialization of novel cancer therapeutics and diagnostics. The company has operations in Dallas, Rockville, and New York. PBI is headquartered in Dallas, Texas, the US.

Precision Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Precision Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Precision Biologics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Precision Biologics Raises USD53 Million in Financing Round 11
Precision Biologics Raises USD0.79 Million in Venture Financing 12
Precision Biologics Raises USD10.5 Million in Venture Financing 13
Precision Biologics Raises US$3.3 Million In Venture Financing 14
Precision Biologics Raises USD5.3 Million in Venture Financing 15
Partnerships 16
Precision Biologics Enters into R&D Agreement with National Cancer Institute 16
Merck Enters into Development Agreement with Precision Biologics 17
Licensing Agreements 18
Selexis Enters Into Licensing Agreement With Neogenix Oncology 18
Acquisition 19
NantWorks Acquires Majority Stake in Precision Biologics for USD50 Million 19
Precision Biologics Completes Acquisition Of Neogenix Oncology 20
Precision Biologics Inc - Key Competitors 21
Precision Biologics Inc - Key Employees 22
Precision Biologics Inc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Clinical Trials 24
Apr 02, 2017: Precision Biologics to Highlight Preclinical Data on NEO-201, a Neoantigen Targeting Antibody in Oral Presentation at the 110th Annual Meeting of the American Association of Clinical Research 24
Apr 17, 2016: Precision Biologics, a NantWorks Company, to Present Combination Immunotherapy of a Novel Neo-Epitope Antibody Targeting Ovarian and Uterine Cancer at the AACR Annual Meeting 2016 25
Jan 21, 2016: Cancer MoonShot 2020 Reaches First Clinical Trial Milestone: Immunotherapy Trial Demonstrates Encouraging Survival Rates in Patients with Metastatic Colorectal Cancer Who Failed All Standard Therapy 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Precision Biologics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Precision Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Precision Biologics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Precision Biologics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Precision Biologics Raises USD53 Million in Financing Round 11
Precision Biologics Raises USD0.79 Million in Venture Financing 12
Precision Biologics Raises USD10.5 Million in Venture Financing 13
Precision Biologics Raises US$3.3 Million In Venture Financing 14
Precision Biologics Raises USD5.3 Million in Venture Financing 15
Precision Biologics Enters into R&D Agreement with National Cancer Institute 16
Merck Enters into Development Agreement with Precision Biologics 17
Selexis Enters Into Licensing Agreement With Neogenix Oncology 18
NantWorks Acquires Majority Stake in Precision Biologics for USD50 Million 19
Precision Biologics Completes Acquisition Of Neogenix Oncology 20
Precision Biologics Inc, Key Competitors 21
Precision Biologics Inc, Key Employees 22
Precision Biologics Inc, Other Locations 23
Precision Biologics Inc, Subsidiaries 23
List of Figures
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Precision Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Precision Biologics Inc, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter